Anti-PD-1/HER-2/LAG-3 trispecific monoclonal antibody (Sunshine GuoJian)

PD-1/HER-2/LAG-3六价三特异性抗体（三生国健）

Report date: 2025/02/18 15:10:33

Base Information

Drug NameAnti-PD-1/HER-2/LAG-3 trispecific monoclonal antibody (Sunshine GuoJian)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsProgrammed cell death protein 1 blockersAnti-Lymphocyte activation gene 3 protein
TargetsReceptor protein-tyrosine kinase erbB-2Programmed cell death protein 1Lymphocyte activation gene 3 protein
Therapy Area/IndicationsAutoimmune DiseasesNeoplasmsHIV Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasmsHIV Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A